Pharmaceutical compositions for the treatment of fungal infections

Details for Australian Patent Application No. 2011221426 (hide)

Owner Novartis AG

Inventors Mayer, Friedrich Karl

Agent Davies Collison Cave

Pub. Number AU-A-2011221426

Parent 2007291517

Filing date 9 September 2011

Wipo publication date 29 September 2011

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/69 (2006.01) - Boron compounds

A61P 31/10 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

22 September 2011 Complete Application Filed

29 September 2011 Application Open to Public Inspection

  Published as AU-A-2011221426

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011221427-BIS closed loop anesthetic delivery

2011221425-High flexion articular insert